Skip to main content

Abstract

This review surveys briefly some of the contributions of medicinal chemistry to medicine of the past 30 years and identifies some new problems. This period was ushered in dramatically with the discovery of chemotherapeutic sulfonamides. Succeeding years witnessed a veritable revolution in medical practice largely stemming from drug discoveries to which medicinal chemists made major contributions. This also represents the productive period of many individuals who are now reaching the concluding years of their active careers in this type of research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. R. F. Clapp, Study of Drug Purchase Problems and Policies, U.S. Department of Health, Education and Welfare, Welfare Research Report 2, March 1966 (Superintendent of Documents, U.S. Government Printing Office, Washington, D.C.).

    Google Scholar 

  2. Prescription Drug Industry Fact Book (Pharmaceutical Manufacturers Association, Washington, D.C. 1967); also, Office of Economic Research, Pharmaceutical Manufacturers Association.

    Google Scholar 

  3. Pharmaceutical Preparations, Except Biologicals. Current Industrial Reports (U.S. Dept. of Commerce, Bureau of the Census, Industry Division, Washington, D.C).

    Google Scholar 

  4. Facts on the Major Killing and Crippling Diseases in the United States Today (The National Health Education Committee Inc., New York 1966).

    Google Scholar 

  5. V. du Vigneaud, Science 123, 967 (1956).

    Article  Google Scholar 

  6. A. P. Ryle, F. Sanger, L. F. Smith and R. Kitai, Biochem. J. 60, 541 (1955).

    Google Scholar 

  7. S. Bergstrom and B. Samuelsson, Ann. Rev. Biochem. 34, 101 (1966).

    Article  Google Scholar 

  8. G. Zbinden, in: Molecular Modification in Drug Design (Amer. Chem. Soc., Advances in Chemistry Series, 45, Washington 1964), p. 25.

    Chapter  Google Scholar 

  9. L. P. Garrod, in: Molecular Modification in Drug Design (Amer. Chem. Soc., Advances in Chemistry Series, 45, Washington 1964), p. 39.

    Chapter  Google Scholar 

  10. A Report on the Social and Economic Benefits of the Pharmaceutical Industry in the United States (Arthur D. Little Inc., Cambridge, Mass. 1961).

    Google Scholar 

  11. Cost Analyses of Selected Diseases, a report to the Pharmaceutical Manufacturers Association (Arthur D. Little Inc., Cambridge, Mass. 1967).

    Google Scholar 

  12. J. M. Sprague, in: Molecular Modification in Drug Design (Amer. Chem. Soc., Advances in Chemistry Series, 45, Washington 1964), p. 87.

    Chapter  Google Scholar 

  13. E. D. Freis, in: Molecular Modification in Drug Design (Amer. Chem. Soc., Advances in Chemistry Series, 45, Washington 1964), p. 67.

    Chapter  Google Scholar 

  14. C. J. Cavallito, in: Molecular Modification in Drug Design (Amer. Chem. Soc., Advances in Chemistry Series, 45, Washington 1964), p. 77.

    Chapter  Google Scholar 

  15. I. H. Page, in: Molecular Modification in Drug Design (Amer. Chem. Soc., Advances in Chemistry Series, 45, Washington 1964), p. 50.

    Chapter  Google Scholar 

  16. P. de Haen, American Professional Pharmacist, Nov. 1967, pp. 25–62.

    Google Scholar 

  17. Resources for Medical Research. Report No. 10, U.S. Department of Health, Education and Welfare, Public Health Service, Jan. 1967 (Superintendent of Documents, U.S. Government Printing Office, Washington).

    Google Scholar 

  18. Part 4 — Department of Health, Education and Welfare Appropriations for 1967 (National Institutes of Health) 1966 (Superintendent of Documents, U.S. Government Printing Office, Washington).

    Google Scholar 

  19. P. de Haen, New Products Parade 1966 (Paul de Haen, 11 West 42nd St., New York, N.Y.).

    Google Scholar 

  20. R. G. Denkewalter and M. Tishler, in: Progress in Drug Research, Vol. 10, ed. By E. Jucker (Birkhäuser; Basel 1966), p. 11.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1968 Springer Basel AG

About this chapter

Cite this chapter

Cavallito, C.J. (1968). Contributions of Medicinal Chemistry to Medicine — from 1935. In: Jucker, E. (eds) Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques, vol 12. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7065-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7065-8_1

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-7067-2

  • Online ISBN: 978-3-0348-7065-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics